BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 10, 2015
View Archived Issues
Phylogica's 1746-Omomyc fusion reduces tumor size in mouse model of breast cancer
Read More
Celyad provides update on C-Cure in Europe
Read More
Lundbeck reviews key events of third quarter 2015
Read More
Celgene offers pipeline update for third quarter 2015
Read More
Investigators present first-in-human results of JF-04 stent for coronary lesions
Read More
Squamous NSCLC response rate improved when necitumumab added to paclitaxel-carboplatin
Read More
RedHill Biopharma and IntelGenx confirm first European approval of Rizaport
Read More
FDA grants breakthrough therapy designation to SD-809 for tardive dyskinesia
Read More
Kite Pharma begins phase II trial of KTE-C19 mantle cell lymphoma
Read More
PhaseBio begins phase IIa study of once-weekly basal insulin, PE0-139
Read More
Caldan Therapeutics finances development of antidiabetic free fatty acid receptor modulators
Read More
FDA grants tentative approval to Xtampza for chronic pain
Read More
Pivotal phase III trial of RSV-F vaccine in older adults gets started by Novamax
Read More
Astellas to establish presence in ophthalmology through acquisition of Ocata Therapeutics
Read More
Pfizer reports development of dopamine D1 receptor ligands
Read More
Novartis discloses PI3K-gamma inhibitors
Read More
Idenix Pharmaceuticals divulges anti-HCV nucleosides
Read More
Gruenenthal patents Cav2.2 blockers
Read More
AbbVie presents CSF-1R inhibitors
Read More
Na-GST-1/Alhydrogel hookworm vaccine well tolerated and immunogenic in phase I studies
Read More
Nerviano Medical Sciences characterizes JAK-2 inhibitor NMS-P113
Read More
Biosimilar etanercept achieves endpoints in phase III psoriasis study
Read More
Fera Pharmaceuticals licenses U.S. rights to NicOx's naproxcinod
Read More
Janssen licenses rights to Hanmi's oxyntomodulin-based therapies
Read More
New genetic factors linked to persistent ADHD
Read More
ATR inhibitor VX-970 in advanced cancer
Read More
Proteome Sciences reports data on CK1d inhibitors for Alzheimer's disease
Read More
PZ-128 shows clinical promise
Read More